← Insider buys
TERN

Terns Pharmaceuticals, Inc. · Healthcare

Director Jill M. Quigley sold $172K of Terns Pharmaceuticals, Inc.

Sold$172,350
$10.00Price
17,235Shares
−53%Stake

What TERN did after the filing

Filed Sep 11Copier in Sep 12
The stock from Thu, Sep 12 open, $10.85
−37.8%
S&P 500, same days
+4.7%

Measured over 30 trading days, to the Oct 24 close.

Traded Mon, Sep 9. Filed Wed, Sep 11, 6:00 PM ET, after the close. Returns use the Sep 12 open and the Oct 24 close. Not investment advice.